Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 20;16(3):100758.
doi: 10.1016/j.waojou.2023.100758. eCollection 2023 Mar.

A narrative review of recent literature of the quality of life in hereditary angioedema patients

Herberto José Chong-Neto  1
Affiliations
Review

A narrative review of recent literature of the quality of life in hereditary angioedema patients

Herberto José Chong-Neto. World Allergy Organ J. .

Abstract

Hereditary angioedema (HAE) is a rare disorder that causes unpredictable and debilitating cutaneous and submucosal edema and can lead to death. HAE can impair patients' ability to perform daily activities, proportional to pain severity, with patients reporting lower productivity, missed time from work or school and potentially resulting in missed career and educational opportunities. Many patients with HAE experience a significant psychological burden, including anxiety and depression. Available treatment aims to prevent and/or treat HAE attacks as they occur, to reduce morbidity and mortality and, finally, to improve health-related quality of life. Two different validated specific angioedema instruments are available to assess patients' quality of life. The Angioedema Quality of Life Questionnaire (AE-QoL) examines diagnosed patients' quality of life but is not specific for HAE. The disease-specific questionnaire is the Hereditary Angioedema Quality of Life (HAE-QoL), and the first used for hereditary angioedema with C1 inhibitors (C1-INH) deficiency. These quality-of-life instruments are helpful to the HAE patients' assessment and to the development of better therapeutic strategies as clinical tools, as defined by international guidelines. Considering this context, this review was conducted to compare the effects of acute vs. long-term prophylaxis on HAE patients' health-related quality of life. In addition, the prevalence of anxiety and depression among these individuals was also reviewed.

Keywords: Angioedema; Health-related quality of life; Hereditary; Patient reported outcome measures; Preventive therapy; Questionnaire.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Busse P.J., Christiansen S.C. Hereditary angioedema. N Engl J Med. 2020;382(12):1136–1148. doi: 10.1056/NEJMra1808012. - DOI - PubMed
    1. Wilkerson R.G., Moellman J.J. Hereditary angioedema. Emerg Med Clin North Am. 2022;40(1):99–118. doi: 10.1016/j.emc.2021.09.002. - DOI - PubMed
    1. Longhurst H.J., Bork K. Hereditary angioedema: an update on causes, manifestations and treatment. Br J Hosp Med. 2019;80(7):391–398. doi: 10.12968/hmed.2019.80.7.391. - DOI - PubMed
    1. Bowen T., Cicardi M., Bork K., et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol. 2008;100(1):S30–S40. doi: 10.1016/S1081-1206(10)60584-4. - DOI - PubMed
    1. Zuraw B.L. Hereditary angioedema. N Engl J Med. 2008;359(10):1027–1036. doi: 10.1056/NEJMcp0803977. - DOI - PubMed

LinkOut - more resources